Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

October 12, 2016

Primary Completion Date

October 18, 2018

Study Completion Date

June 7, 2022

Conditions
Colorectal Cancer
Interventions
DRUG

Tremelimumab

DRUG

Durvalumab

OTHER

Best Supportive Care

Trial Locations (25)

T2N 4N2

Tom Baker Cancer Centre, Calgary

V5Z 4E6

BCCA - Vancouver Cancer Centre, Vancouver

E1C 6Z8

The Moncton Hospital, Moncton

A1B 3V6

Dr. H. Bliss Murphy Cancer Centre, St. John's

B3H 1V7

QEII Health Sciences Centre, Halifax

L4M 6M2

Royal Victoria Regional Health Centre, Barrie

L8V 5C2

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

K7L 5P9

Cancer Centre of Southeastern Ontario at Kingston, Kingston

N6A 5W9

London Regional Cancer Program, London

K1H 8L6

Ottawa Hospital Research Institute, Ottawa

P6B 0A8

Algoma District Cancer Program, Sault Ste. Marie

M4N 3M5

Odette Cancer Centre, Toronto

M5G 2M9

University Health Network, Toronto

N8W 2X3

Windsor Regional Cancer Centre, Windsor

J4V 2H1

Hopital Charles LeMoyne, Greenfield Park

H7M 3L9

Hopital de la Cite-de-la-Sante, Laval

G6V 3Z1

L'Hotel-Dieu de Levis, Lévis

H2L 4M1

CHUM - Hopital Notre-Dame, Montreal

H3T 1E2

The Jewish General Hospital, Montreal

H4J 1C5

Centre Integre Universitaire De Sante Et De Services, Montreal

G1R 2J6

CHUQ-Pavillon Hotel-Dieu de Quebec, Québec

J1H 5N4

Centre hospitalier universitaire de Sherbrooke, Sherbrooke

G8Z 3R9

Centre hospitalier regional de Trois-Rivieres, Trois-Rivières

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Canadian Cancer Trials Group

NETWORK